Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one)

Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one) 구조식 이미지
카스 번호:
63309-35-3
상품명:
Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one)
동의어(영문):
elated Compound;Aripiprazole impurities1757;5-(4-BroMobutoxy)-3,4-dihydro-2(1H)-quinolinone;2(1H)-Quinolinone, 5-(4-bromobutoxy)-3,4-dihydro-;(5-(4-bromobutoxy)-3,4-dihydroquinolin-2(1H)-one);Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one)
CBNumber:
CB72706615
분자식:
C13H16BrNO2
포뮬러 무게:
298.18
MOL 파일:
63309-35-3.mol
MSDS 파일:
SDS

Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one) 속성

끓는 점
473.0±45.0 °C(Predicted)
밀도
1.383±0.06 g/cm3(Predicted)
산도 계수 (pKa)
14.38±0.20(Predicted)

안전

Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one) C화학적 특성, 용도, 생산

Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one) 준비 용품 및 원자재

원자재

준비 용품


Aripiprazole Related CoMpound (5-(4-broMobutoxy)-3,4-dihydroquinolin-2(1H)-one) 공급 업체

글로벌( 26)공급 업체
공급자 전화 이메일 국가 제품 수 이점
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
jkinfo@jkchemical.com China 94838 76
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Nanjing XiZe Biotechnology CO., Ltd. 025-58362220 15250997978
1511893459@qq.com China 7715 55
Shanghai Xiang Xin Industrial Co., Ltd. 021-50211651 13651607026
sales@xxgmpharm.com China 487 58
BOC Sciences 16314854226
info@bocsci.com United States 9926 65
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 7848 55
Shanghai CR Corporation Limited 4006653949
fred.wen@crcorporation.cn China 10108 58

Copyright 2019 © ChemicalBook. All rights reserved